Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole

DRUG2 trials

Sponsors

Forest Laboratories, Gala Servicios Clinicos S.L.

Conditions

DyspepsiaGastrointestinal Adverse EffectsHelicobacter InfectionsHelicobacter Pylori Infection

Phase 3

Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

CompletedNCT00669955

Forest LaboratoriesHelicobacter Infections

Start: 2008-06-30End: 2009-08-31Updated: 2017-03-16

Unknown Phase

Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection

Not yet recruitingNCT07729293

Gala Servicios Clinicos S.L.Dyspepsia, Gastrointestinal Adverse Effects, Helicobacter Pylori Infection

Start: 2026-08-31End: 2028-09-30Target: 140Updated: 2026-07-27

Related Papers

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.

2011-02-21349 citations